_MACHINE TRANSLATION_
The Management Board of Bioceltix S.A., with its registered office in Wrocław (the “Company”), hereby announces that on 7 January 2026 the National Depository for Securities S.A. (Krajowy Depozyt Papierów Wartościowych S.A., “KDPW”) issued Statement No. 8/2026 regarding the conclusion with the Company of an agreement on the registration in the securities depository maintained by KDPW of 150,000 ordinary bearer shares of the Company of series O (the “Shares”) under ISIN code PLBCLTX00019.
The registration of the Shares is conditional upon their admission to trading on the regulated market (parallel market) operated by the Warsaw Stock Exchange S.A. (“WSE”), on which the Company’s remaining shares designated with the above-mentioned ISIN code have been admitted to trading.
The registration of the Shares will take place within 3 days from the date on which KDPW receives the resolution of the Management Board of the WSE on the admission of the Shares to trading on the regulated market operated by the WSE, but not earlier than on the date indicated in such resolution as the date of admission of the Shares to trading.
Signatures of persons representing the Company:
Łukasz Bzdzion – President of the Management Board
Paweł Wielgus – Member of the Management Board
_MACHINE TRANSLATION_